Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of the combination of Avastin and
Docetaxel in the treatment of women with platinum sensitive recurrent epithelial ovarian
cancer within 12 months of platinum chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
Genentech, Inc. National Cancer Institute (NCI) Sanofi